Equibles does not estimate personal net worth.
Get an email with a short summary when Iovance Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get IOVA alertsNoah Berkowitz has spoken on 1 earnings call across 1 company, most recently for Iovance Biotherapeutics, Inc. on November 5, 2026. Iovance Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Iovance Biotherapeutics, Inc. includes Frederick G. Vogt, Ph.D. (CEO), Frederick Vogt (CEO and General Counsel), Corleen Roche (CFO) and 7 others.
“Having joined the company a month ago, this is my first iAvance earnings call, and I am incredibly happy to be here. I joined iAvance because TIL is the first single administration cell therapy that achieves deep and lasting responses in a significant proportion of patients.”
Transcript header (unverified)
Biotechnology · Healthcare
